Stock Rich List
Nasdaq: DMAC

DiaMedica Therapeutics insiders

The officers, directors and 10% owners of DiaMedica Therapeutics Inc. who hold the most stock, valued at the live DMAC price.

$8.02
DMAC today −$570K (−6.64%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
6
Their DMAC stock
$362M
Market value
$463M
Held by ranked insiders
78.0%

Insiders by value of DMAC holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Jan Stahlberg10% owner14,528,930$117M25.1%1349th
2Ab Trill10% owner8,825,742$70.8M15.3%1971st
3Thomas Von Koch10% owner8,383,577$67.2M14.5%2057th
4Private Ab TomEnterprise10% owner5,526,435$44.3M9.56%2772nd
5Richard Jacinto II10% owner4,958,823$39.8M8.58%3032nd
6Ab TomEnterprise10% owner2,855,827$22.9M4.94%4683rd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for DiaMedica Therapeutics; see each profile for the filing.